Cargando…
A CONTROVERSY: WARFARIN FAILURE IN COVID-19 WITH SUPRATHERAPEUTIC INR
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Cardiology Foundation. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982919/ http://dx.doi.org/10.1016/S0735-1097(23)03821-4 |
_version_ | 1784900432810737664 |
---|---|
author | Ur Rahman, Saad |
author_facet | Ur Rahman, Saad |
author_sort | Ur Rahman, Saad |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9982919 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American College of Cardiology Foundation. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99829192023-03-03 A CONTROVERSY: WARFARIN FAILURE IN COVID-19 WITH SUPRATHERAPEUTIC INR Ur Rahman, Saad J Am Coll Cardiol Complex Clinical Cases American College of Cardiology Foundation. Published by Elsevier Inc. 2023-03-07 2023-03-03 /pmc/articles/PMC9982919/ http://dx.doi.org/10.1016/S0735-1097(23)03821-4 Text en © 2023 American College of Cardiology Foundation Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Complex Clinical Cases Ur Rahman, Saad A CONTROVERSY: WARFARIN FAILURE IN COVID-19 WITH SUPRATHERAPEUTIC INR |
title | A CONTROVERSY: WARFARIN FAILURE IN COVID-19 WITH SUPRATHERAPEUTIC INR |
title_full | A CONTROVERSY: WARFARIN FAILURE IN COVID-19 WITH SUPRATHERAPEUTIC INR |
title_fullStr | A CONTROVERSY: WARFARIN FAILURE IN COVID-19 WITH SUPRATHERAPEUTIC INR |
title_full_unstemmed | A CONTROVERSY: WARFARIN FAILURE IN COVID-19 WITH SUPRATHERAPEUTIC INR |
title_short | A CONTROVERSY: WARFARIN FAILURE IN COVID-19 WITH SUPRATHERAPEUTIC INR |
title_sort | controversy: warfarin failure in covid-19 with supratherapeutic inr |
topic | Complex Clinical Cases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982919/ http://dx.doi.org/10.1016/S0735-1097(23)03821-4 |
work_keys_str_mv | AT urrahmansaad acontroversywarfarinfailureincovid19withsupratherapeuticinr AT urrahmansaad controversywarfarinfailureincovid19withsupratherapeuticinr |